Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
M.D. Anderson Cancer Center
Eli Lilly and Company
Institut Claudius Regaud
City of Hope Medical Center
M.D. Anderson Cancer Center
Eli Lilly and Company
University of Arizona
Sanofi
Sanofi
Exelixis
Peking Union Medical College Hospital
Jonsson Comprehensive Cancer Center
University of Pennsylvania
University Medical Center Groningen
Hoffmann-La Roche
Instituto do Cancer do Estado de São Paulo
Sanofi
Eli Lilly and Company
Eli Lilly and Company
National Cancer Institute (NCI)